Walleye Trading LLC Esperion Therapeutics, Inc. Call Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$1.84 - $3.24 $91,632 - $161,352	-49,800 Reduced 8.66%	525,200 $1.17 Million
Q1 2024 May 15, 2024	SELL	$2.02 - $3.02 $966,974 - $1.45 Million	-478,700 Reduced 45.43%	575,000 $1.54 Million
Q4 2023 Feb 14, 2024	BUY	$0.73 - $3.08 $693,208 - $2.92 Million	949,600 Added 912.2%	1,053,700 $3.15 Million
Q3 2023 Nov 14, 2023	SELL	$0.96 - $1.79 $77,280 - $144,095	-80,500 Reduced 43.61%	104,100 $102,000
Q2 2023 Aug 14, 2023	SELL	$1.2 - $1.76 $142,800 - $209,440	-119,000 Reduced 39.2%	184,600 $256,000
Q1 2023 May 15, 2023	BUY	$1.46 - $7.3 $58,400 - $292,000	40,000 Added 15.17%	303,600 $482,000
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $109,944 - $183,600	21,600 Added 8.93%	263,600 $1.64 Million
Q3 2022 Nov 14, 2022	BUY	$5.45 - $8.13 $289,395 - $431,703	53,100 Added 28.11%	242,000 $1.62 Million
Q2 2022 Aug 08, 2022	BUY	$4.77 - $6.67 $434,069 - $606,970	91,000 Added 92.95%	188,900 $1.2 Million
Q1 2022 May 16, 2022	BUY	$3.34 - $5.56 $150,968 - $251,311	45,200 Added 85.77%	97,900 $454,000
Q4 2021 Feb 14, 2022	SELL	$4.81 - $11.92 $14,910 - $36,952	-3,100 Reduced 5.56%	52,700 $264,000
Q3 2021 Nov 15, 2021	BUY	$11.34 - $21.37 $514,836 - $970,198	45,400 Added 436.54%	55,800 $672,000
Q2 2021 Aug 16, 2021	SELL	$19.4 - $28.71 $71,780 - $106,227	-3,700 Reduced 26.24%	10,400 $220,000
Q1 2021 May 17, 2021	SELL	$25.12 - $36.89 $271,296 - $398,412	-10,800 Reduced 43.37%	14,100 $396,000
Q4 2020 Feb 16, 2021	BUY	$24.2 - $35.76 $602,580 - $890,424	24,900 New	24,900 $647,000
Q3 2020 Nov 16, 2020	SELL	$31.18 - $52.71 $327,390 - $553,455	-10,500 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.04 - $51.31 $30,040 - $51,310	1,000 Added 10.53%	10,500 $539,000
Q1 2020 May 15, 2020	SELL	$27.44 - $73.84 $131,712 - $354,432	-4,800 Reduced 33.57%	9,500 $300,000
Q4 2019 Feb 14, 2020	BUY	$35.4 - $59.82 $258,420 - $436,686	7,300 Added 104.29%	14,300 $853,000
Q3 2019 Nov 14, 2019	BUY	$34.47 - $47.53 $68,940 - $95,060	2,000 Added 40.0%	7,000 $257,000
Q2 2019 Aug 14, 2019	SELL	$40.1 - $52.33 $613,530 - $800,649	-15,300 Reduced 75.37%	5,000 $233,000
Q1 2019 May 15, 2019	SELL	$40.11 - $53.57 $501,375 - $669,625	-12,500 Reduced 38.11%	20,300 $815,000
Q4 2018 Feb 14, 2019	BUY	$36.99 - $59.11 $1.21 Million - $1.94 Million	32,800 New	32,800 $1.51 Million
Q3 2018 Nov 14, 2018	SELL	$40.74 - $51.41 $281,106 - $354,729	-6,900 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$36.2 - $76.4 $249,780 - $527,160	6,900 New	6,900 $270,000

Others Institutions Holding ESPR

# of Institutions

206

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $153M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account